Home > Insider Trading > Filing (0000899243-16-024049)

Filing Details

Accession Number:: 0000899243-16-024049
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-07-01 16:06:19
Reporting Period:: 2016-06-30

Filing Date:: 2016-07-01
Accepted Time:: 2016-07-01 16:06:19
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1174940	Oragenics Inc	OGEN.BC	Pharmaceutical Preparations (2834)	593410522

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1234877	Beverly Koski	3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219	No	No	Yes	No
1234878	L Christine Koski	3525 Turtle Creek Bouldevard, Unit 19-B Dallas TX 75219	No	No	Yes	No
1234879	Koski Family Lp	3525 Turtle Creek Boulevard, Unit 19-B Dallas TX 75219	No	No	Yes	No
1234880	C Robert Koski	7362 Hawkins Road Sarasota FL 34241	Yes	No	Yes	No
1234881	L Thomas Koski	4995 Ashley Parkway Sarasota FL 34241	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-06-30	5,815,080	$0.52	12,864,822	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,572,523	Direct
Common Stock	1,007,878	Direct
Common Stock	919,666	Direct
Common Stock	28,000	Indirect	By Koski Management, Inc.
Common Stock	530,851	Indirect	By Trusts

Footnotes

The shares were acquired pursuant to a private placement conducted by the Company.
Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Shares owned directly by Christine L. Koski.
Shares owned directly by Robert C. Koski, a director of the Company.
Shares owned directly by Thomas L. Koski.
Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.